indobufen has been researched along with Arterial Occlusive Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballatori, E; Berrettini, M; Iadevaia, V; Nenci, GG; Parise, P | 1 |
| Celi, V; Chello, M; Colonna, A; Marchese, AR; Mastroroberto, P; Romano, F | 1 |
| Costa, F; Rossini, A; Tascino, C | 1 |
| Calacoci, S; Landini, G; Marino, N; Poggiali, C; Rosselli, A | 1 |
5 trial(s) available for indobufen and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests.
Topics: Aged; Antithrombins; Arterial Occlusive Diseases; Blood Coagulation; Double-Blind Method; Fibrinolysis; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Adhesiveness; Platelet Aggregation; Time Factors | 1982 |
Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arterial Occlusive Diseases; Cyclooxygenase Inhibitors; Humans; Intermittent Claudication; Isoindoles; Lactic Acid; Middle Aged; Neutrophil Activation; Phenylbutyrates; Platelet Aggregation Inhibitors; Thromboxane B2 | 1996 |
[Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Heparitin Sulfate; Humans; Intermittent Claudication; Isoindoles; Leg; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors | 1998 |
[Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Drug Evaluation; Humans; Isoindoles; Leg; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Random Allocation | 1989 |
Long-term antiplatelet activity and safety of indobufen in patients with cardiovascular disease. Italian Multicenter Study Group.
Topics: Adult; Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Drug Tolerance; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Isoindoles; Male; Middle Aged; Patient Compliance; Phenylbutyrates; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Time Factors | 1985 |